Therapeutic Trial of Modified Levofloxacin (MOLVX) Against Induced Colorectal Aberrant Crypt Foci (Precancerous Tissue) in Mice. Iraqi J. Vet. Med. 2022, 46 (2), 53-65. https://doi.org/10.30539/ijvm.v46i2.1554.